Gapping up
In reaction to earnings/guidance:
- GIII +5.9%
M&A news:
- USCR +27.8% (U.S. Concrete to be acquired by Vulcan (VMC) for $74.00 per share in cash)
- MIC +12.8% (MacQuarie Infrastructure announces agreement to sell Atlantic Aviation to (KKR) for $4.475 bln) .
Other news:
- ADMP +14% (highlights that the National Institutes of Health has identified its experimental drug, Tempol, as a potentially potent antiviral for COVID-19)
- CDXC +13% (ChromaDex and Walmart (WMT) launch Tru Niagen in 3,800 Walmart stores across the United States)
- UIHC +6.3% (files $100 mln mixed securities shelf offering)
- GLSI +4.8% (publishes additional positive safety data from GP2 phase IIb trial at ASCO 2021)
- AMYT +3.5% (receives confirmation from FDA that Oleogel-S10 will not require an Advisory Committee Meeting)
- FLGC +2.5% (expands into EU)
- AMC +2.2% (continued volatility)
- IOVA +2% (ASCO presentation)
- VLDR +1.9% (announced Seabed B.V., which specializes in high quality equipment for offshore surveying and dredging, has selected Puck sensors for its lidar mobile mapping system)
- DPW +1.5% (to expand the infrastructure of its technology data center in southern Michigan and increase the power capacity to 28MW)
- TMST +1.1% (will increase base pricing by $50 per ton on all special bar quality products)
- STMP +1.1% (settles securities class action lawsuit, net cash outflow expected at $66-77 mln)
- VVNT +1% (appoints David Bywater as CEO)
Analyst comments:
- NEXT +29.5% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- MRUS +5.8% (upgraded to Buy from Neutral at Citigroup)
- CHRW +2.7% (double-upgraded to Buy from Sell at Goldman)
- AZUL +2.6% (upgraded to Outperform from Neutral at Bradesco BBI)
- FATE +1.3% (upgraded to Buy from Neutral at H.C. Wainwright)
- V +1.2% (upgraded to Overweight from Neutral at Piper Sandler)